For one ICU physician and startup CMO, the more immediate danger isn’t an autonomous system taking over medicine and leaving ...

The FDA is recruiting to fill vacancies on its advisory committees, informally known as adcomms. While these committees have ...

Jimini Health has raised $17 million in seed funding to help behavioral health organizations safely deploy AI at scale, the company announced on Tuesday. The New York-based company is building ...

AstraZeneca’s equity investment in Summit Therapeutics comes with plans for clinical trial collaborations. The deal brings ...

Pelago launched a behavioral health platform that integrates substance use, mental health and behavioral addiction care, ...

Mirum Pharmaceuticals’ Atebrioz is the third FDA-approved drug for fibrodysplasia ossificans progressiva (FOP), but it brings ...

When drug prices are too high for patients, physicians take on additional workload to find solutions. A newly released 2026 ...

Eli Lilly’s partnership with InnoCare Pharma follows deals struck this year with other China-based companies. While ...

DreaMed Diabetes has received FDA 510(K) clearance for MODI, a mobile app that uses CGM (continuous glucose monitoring) data ...

The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ...

Merck now has global rights to a SciBrunch Therapeutics drug candidate designed to block mutated versions of the ...